Post-doctoral fellowship in NGS bioinformatics in cancer research (Lund, Sweden)
Post-doctoral fellowship in bioinformatics and next-generation sequencing analysis in cancer research
Responsibilities: We are seeking a qualified bioinformatician to work on next-generation sequencing projects in the area of cancer DNA-seq mutation analysis and RNA-seq gene expression profiling (Translational Oncogenomics Unit) as well as characterization of DNA binding proteins by ChIP-seq (Functional Genomics Unit), and integration of these datasets with other genomic data such as from SNP/CNV arrays, gene expression microarrays, as well as with clinicopathological and patient data. Projects underway will analyze over 1500 human tumors per year on our two Illumina GA IIx's and HiSeq 2000 sequencers, two in-house computing clusters, as well as utilizing the available national computing infrastructure.
The successful applicant will be working in close collaboration with other research Units of the Canceromics Branch (including a half-dozen other bioinformaticians) as well as within national and international collaborations.
Requirements: Applicants must hold a PhD in bioinformatics/computer science/mathematics or equivalent and have a strong desire to work in the field of bioinformatics and cancer research. The successful applicant will be well versed in computer programming, with previous experience with analysis of next-generation sequencing data and scripting using R/Bioconductor/perl being a plus.
The duration of the position will be at least 2 years.
To apply: send, via email, a CV, statement of research interests, and the names and contact information for three references.
Applications and inquires should be addressed to:
Lao Saal, MD PhD
Head, Translational Oncogenomics Unit
[email protected]
AND
Sofia Gruvberger, PhD
Head, Functional Genomics Unit
[email protected]
For more information, visit http://www.med.lu.se/english/klinvet...open_positions
---
About Lund University
Founded in 1666, Lund University is today one of the largest, oldest and broadest universities in Scandinavia and is consistently ranked among the world's top 100 universities. Lund University has an excellent academic reputation with a large number of visiting professors and international students.
Lund University is Sweden's strongest research university and in recent years has been awarded more research funding than any other Swedish higher education institution. This success can largely be attributed to the inter-disciplinary research that is carried out and the diversity that our full-scale University can offer.
In 2009 Lund University received strategic research funding of SEK 715 million from the Swedish Government in order to lead and develop world-leading research in nine different areas over a period of five years, including cancer research.
Around 46,000 students study at the University, which has some 6,000 employees, and there are close ties to the University Hospital, one of the major regional medical centers.
The two largest research facilities in Sweden - Max-Lab IV and the European Spallation Source (ESS) - will be built in Lund in the coming years. The selection of Lund as the location for these important research facilities reflects the strength and attractiveness of research at Lund University.
For more information visit http://www.lunduniversity.lu.se/
Responsibilities: We are seeking a qualified bioinformatician to work on next-generation sequencing projects in the area of cancer DNA-seq mutation analysis and RNA-seq gene expression profiling (Translational Oncogenomics Unit) as well as characterization of DNA binding proteins by ChIP-seq (Functional Genomics Unit), and integration of these datasets with other genomic data such as from SNP/CNV arrays, gene expression microarrays, as well as with clinicopathological and patient data. Projects underway will analyze over 1500 human tumors per year on our two Illumina GA IIx's and HiSeq 2000 sequencers, two in-house computing clusters, as well as utilizing the available national computing infrastructure.
The successful applicant will be working in close collaboration with other research Units of the Canceromics Branch (including a half-dozen other bioinformaticians) as well as within national and international collaborations.
Requirements: Applicants must hold a PhD in bioinformatics/computer science/mathematics or equivalent and have a strong desire to work in the field of bioinformatics and cancer research. The successful applicant will be well versed in computer programming, with previous experience with analysis of next-generation sequencing data and scripting using R/Bioconductor/perl being a plus.
The duration of the position will be at least 2 years.
To apply: send, via email, a CV, statement of research interests, and the names and contact information for three references.
Applications and inquires should be addressed to:
Lao Saal, MD PhD
Head, Translational Oncogenomics Unit
[email protected]
AND
Sofia Gruvberger, PhD
Head, Functional Genomics Unit
[email protected]
For more information, visit http://www.med.lu.se/english/klinvet...open_positions
---
About Lund University
Founded in 1666, Lund University is today one of the largest, oldest and broadest universities in Scandinavia and is consistently ranked among the world's top 100 universities. Lund University has an excellent academic reputation with a large number of visiting professors and international students.
Lund University is Sweden's strongest research university and in recent years has been awarded more research funding than any other Swedish higher education institution. This success can largely be attributed to the inter-disciplinary research that is carried out and the diversity that our full-scale University can offer.
In 2009 Lund University received strategic research funding of SEK 715 million from the Swedish Government in order to lead and develop world-leading research in nine different areas over a period of five years, including cancer research.
Around 46,000 students study at the University, which has some 6,000 employees, and there are close ties to the University Hospital, one of the major regional medical centers.
The two largest research facilities in Sweden - Max-Lab IV and the European Spallation Source (ESS) - will be built in Lund in the coming years. The selection of Lund as the location for these important research facilities reflects the strength and attractiveness of research at Lund University.
For more information visit http://www.lunduniversity.lu.se/